Rounding up our favorite reporting from 2025

This year saw a lot of changes to the healthcare industry with a new presidential administration coming in, and we were top of how that impacted hospitals, Big Pharma, payers, tech, and retailers.

Here’s what we had the most fun reporting in 2025.

How the Human Genome Project shaped modern medicine

This story was so fun to report because I got to learn about a topic I didn’t know much about (genomics) and talk to some of the people directly involved in the Human Genome Project. I had no idea how many healthcare innovations had stemmed from the project and how much potential there is for genomics to advance healthcare in the future.—MA

As AI therapy grows, clinicians try to chart a path forward

This article provided the opportunity to explore some really important questions, like: What defines therapy’s success? What should AI “therapy” be allowed to promise? And what liability do app developers have? Even within the psychology community, I got different answers. Since we published this article, the topic has become even more relevant and even caught the attention of the FDA.—CC

A day in the life of a hospital in 2000, and what’s changed in 25 years and A look back at the last 25 years in the pharmacy industry

Just one? That’s so hard! I had a really great time working on the Quarter Century Project this year, including these look-backs about how the hospital and retail pharmacy industries have changed in the last 25 years. I got to speak with really experienced clinicians and pharmacists for these pieces, which was a ton of fun and really informative.—CM

Trend report suggests sustainability is still important to hospital leaders

Sustainability has come under fire since the Trump administration took office in January, but this trend report from health sustainability nonprofits Health Care Without Harm and Practice Greenhealth found that healthcare execs are still prioritizing initiatives that will ultimately benefit the environment. Seeing the stats and speaking with leaders to see how they haven’t been deterred from their goals was encouraging to hear about.—NO